Imaging is an integral part of many clinical studies, particularly in the fields of oncology and ophthalmology. Learn why imaging and centralized review are essential for clinical trials, how to address challenges that arise in these studies, and the advantages of partnering with MERIT in this video.
Imaging provides an unbiased, structural assessment of many disease states, which is a complement to functional outcome measures
Centralized imaging review is particularly important in Phase II and III trials where multiple imaging sites are involved
Centralized imaging challenges can be mitigated with 1) imaging expertise, 2) standardization through certified QMS, and 3) an integrated technology platform